# Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular Disease

> **NCT07753031** · — · NOT_YET_RECRUITING · sponsor: **Alcea** · enrollment: 389 (estimated)

## Conditions studied

- Iron Deficiency Anemia
- Coronary Artery Disease
- Heart Failure With Preserved Ejection Fraction (HFPEF)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07753031
- **Lead sponsor:** Alcea
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 389 (ESTIMATED)
- **Last updated:** 2026-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753031, "Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*